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Abstract The median raphe region (MRR) is thought to
be serotonergic and plays an important role in the regula-
tion of many cognitive functions. In the hippocampus
(HIPP), the MRR exerts a fast excitatory control, partially
through glutamatergic transmission, on a subpopulation of
GABAergic interneurons that are key regulators of local
network activity. However, not all receptors of this con-
nection in the HIPP and in synapses established by MRR in
other brain areas are known. Using combined anterograde
tracing and immunogold methods, we show that the
GluN2A subunit of the NMDA receptor is present in the
synapses established by MRR not only in the HIPP, but
also in the medial septum (MS) and in the medial prefrontal
cortex (mPFC) of the mouse. We estimated similar
amounts of NMDA receptors in these synapses established
by the MRR and in local adjacent excitatory synapses.
Using retrograde tracing and confocal laser scanning
microscopy, we found that the majority of the projecting
cells of the mouse MRR contain the vesicular glutamate
transporter type 3 (vGluT3). Furthermore, using double
retrograde tracing, we found that single cells of the MRR
can innervate the HIPP and mPFC or the MS and mPFC
simultaneously, and these double-projecting cells are also
predominantly vGluT3-positive. Our results indicate that
the majority of the output of the MRR is glutamatergic and
acts through NMDA receptor-containing synapses. This
suggests that key forebrain areas receive precisely targeted
excitatory input from the MRR, which is able to synchro-
nously modify activity in those regions via individual MRR
cells with dual projections.
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Introduction
The midbrain raphe nuclei are responsible for the seroto-
nergic innervation of the forebrain (Azmitia and Segal
1978; Vertes and Martin 1988). The dorsal raphe (DR) and
median raphe region (MRR) are thought to play a very
important role in modulating different brain functions like
emotions, mood, learning and memory (Vertes and Kocsis
1997; Hensler 2006). Although they are both serotonergic,
DR and MRR show a very different pattern of innervation
in the forebrain. While DR sends thin fibers establishing
hardly any synaptic contacts, the thick fibers of the MRR
typically influence its targets via synaptic connections
(Kosofsky and Molliver 1987; Leranth and Vertes 1999;
Varga et al. 2009; Bang et al. 2012). The MRR that cor-
responds to the median raphe (MR) and paramedian raphe
(PMR) subregions, strongly innervates many cortical and
subcortical forebrain areas, including the hippocampus
(HIPP), medial septum (MS) and medial prefrontal cortex
(mPFC; Vertes et al. 1999; Bang et al. 2012). Although the
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exact targets of MRR are not known in every innervated
brain area, MRR projection seems to be very specific in the
HIPP and MS. In the HIPP of the rat, MRR establishes
synaptic contacts with the somata or proximal dendrites of
different types of interneurons, except parvalbumin-posi-
tive cells (Freund et al. 1990; Acsa´dy et al. 1993; Papp
et al. 1999; Somogyi et al. 2004; Varga et al. 2009), and
MRR provides a complex modulation of the hippocampal
network activity (Assaf and Miller 1978; Vertes and Kocsis
1997; Jackson et al. 2008). In the MS and diagonal band of
Broca of the rat, MRR fibers give perisomatic and per-
idendritic baskets onto parvalbumin and calbindin-positive
GABAergic cells, specifically (Leranth and Vertes 1999;
Aznar et al. 2004). These cells are in key position to
modulate synchronous network activity in the forebrain
(Freund and Antal 1988; Klausberger 2009).
However, projection fibers of the MRR are not only
serotonergic (Ko¨hler et al. 1982; Ko¨hler and Steinbusch
1982; Aznar et al. 2004). Some of the cells in the MRR that
project to the forebrain also contain vesicular glutamate
transporter type 3 (vGluT3) and are considered to be gluta-
matergic (Varga et al. 2009), although these cells may or may
not be 5HT-positive (Aznar et al. 2004; Jackson et al. 2009).
The exact ratios of these cell types are still not known.
Using in vivo and in vitro optogenetical stimulation,
previously, we described in the rat that MRR can exert a
very fast control of a subpopulation of interneurons in the
HIPP, through both serotonergic and glutamatergic neuro-
transmission (Varga et al. 2009). Whether such a strong
glutamatergic control can be mediated also by NMDA-type
glutamate receptors or whether NMDA receptor-containing
synapses are established by MRR in other target brain areas
is unknown. NMDA receptors are key mediators of gluta-
matergic transmission, playing an important role in syn-
aptic plasticity mechanisms in classical excitatory synapses
(Dingledine et al. 1999; Malenka and Bear 2004).
NMDARs have heterotetrameric structure with two GluN1
subunits and usually with two GluN2 subunits. GluN2
subunits are not transported to the membrane without
forming functional channels with the GluN1 subunits
(Fukaya et al. 2003). If NMDA receptors were present in
the forebrain synapses of the MRR, these connections
would not only be ideal for fast and precise activation or
even synchronous modulation of the target areas, but also
would account for some of the interactions between
glutamatergic and serotonergic modulation described in
many different systems (Maura et al. 2000; MacLean and
Schmidt 2001; Yuen et al. 2005).
Single serotonergic cells of the rat MRR can project to
more than one forebrain areas (Ko¨hler and Steinbusch
1982; Acsa´dy et al. 1996). Although non-serotonergic cells
were also shown in these studies to innervate more brain
areas simultaneously, the neurochemical identity of these
cells was not examined. Therefore, it is still unknown,
whether a single glutamatergic cell of the MRR can project
to more forebrain areas simultaneously.
vGluT3-positive neurons are not necessarily glutama-
tergic in all brain areas; for instance, vGluT3-positive
interneurons are considered to be only GABAegic in the
HIPP (Somogyi et al. 2004). To the best of our knowledge,
no studies confirmed so far that these MRR neurons do act
via glutamate receptors in the mouse and only one of our
previous studies gave evidence that they are indeed gluta-
matergic in the hippocampus of rat (Varga et al. 2009).
Although previously several studies focused on the rat
brain, with the advent of genetic engineering, mouse
became the model animal for most physiological and
anatomical studies, and therefore focusing on this species
makes current and future data more interpretable.
Using anterograde tracing combined with double-labeling
immunoelectron microscopy in the mouse, here we show that
the GluN2A subunit of the NMDA receptors can be present
in the postsynaptic active zone of the synapses established by
the MRR not only in the HIPP, but also in the MS and in the
mPFC. We semiquantitatively estimated that on the average,
there is a similar amount of NMDA receptors in the synapses
established by the MRR compared to that in the local
asymmetric (putative excitatory) synapses.
These glutamatergic synapses may be a key component
of the output of MRR, because in retrograde tracing
experiments combined with immunofluorescent staining,
we found that the majority of the MRR cells projecting to
the HIPP, MS and mPFC are in fact glutamatergic.
Moreover, confocal laser scanning microscopic analysis of
double retrograde tracing experiments revealed that gluta-
matergic MRR neurons project to more than one forebrain
areas. Our results suggest that projections from the MRR
are predominantly glutamatergic, because most cells of the
MRR projecting to the HIPP, MS and mPFC contain
vGluT3, and in addition, projecting cells can act through
synapses containing NMDA receptors. Furthermore, these
cells with bifurcating glutamatergic fibers are optimal to
synchronously excite inhibitory neurons of different fore-
brain areas in a fast and precise manner, which makes the
MRR an ideal and fast glutamatergic modulator of its
forebrain targets.
Materials and methods
Animals and perfusion
All experiments were performed in accordance with the
Institutional Ethical Codex and the Hungarian Act of
Animal Care and Experimentation guidelines, which are in
concert with the European Communities Council Directive
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of September 22, 2010 (2010/63/EU). The Animal Care
and Experimentation Committee of the Institute of
Experimental Medicine of Hungarian Academy of Sci-
ences and the Animal Health and Food Control Station,
Budapest, have also approved the experiments.
Fifteen 29–118 days old male C57BL/6 J wild-type
mice, and a 174 days old vGluT3-/- null-mutant mouse
were sacrificed. For perfusion, mice were anesthetized with
isoflurane followed by an intraperitoneal injection of an
anesthetic mixture (containing 8.3 mg/ml ketamine,
1.7 mg/ml xylazine-hydrochloride, 0.8 mg/ml promethaz-
inium-chloride) to achieve deep anesthesia. After that the
mice were perfused transcardially first with 0.9 % NaCl
solution for 2 min followed by 4 % paraformaldehyde for
40 min and finally with 0.1 M phosphate buffer (PB) for
10 min.
Stereotaxic surgery
Ten 49–118 days old male C57BL/6 J wild-type mice were
anesthetized with isoflurane followed by an intraperitoneal
injection of an anesthetic mixture (containing 8.3 mg/ml
ketamine, 1.7 mg/ml xylazine-hydrochloride in 0.9 % sal-
ine, 10 ml/kg body weight) and then were mounted in a
stereotaxic frame. For anterograde tracing experiments, we
injected 5–9 nl 5 % solution of the anterograde tracer
biotinylated dextran amine (Lanciego and Wouterlood
2011, BDA; molecular weight 10 kDa; Molecular Probes)
into the MRR of three mice. The coordinates for the
injection were 4.4 mm posterior from the bregma, in the
midline, and 4.5 mm below the level of the horizontal
plane defined by the bregma and the lambda (zero level).
For the injections, we used a Recording Nanoject-R pre-
cision microinjector pump (Drummond, Broomall, PA).
We used borosilicate micropipettes (Drummond, Broomall,
PA) for the injections with tips broken to 28–36 lm. We
tested, if the 10 kDa BDA could travel retrogradely as well
in the injected brains, but we found only a very few ret-
rogradely labelled cells in the close vicinity of the MRR,
which are highly unlikely to have any fibers in the exam-
ined areas. For double retrograde tracing experiments, first,
we injected the retrograde tracer 2 % Fluoro-Gold (FG;
Fluorochrome, Denver, CO, USA) into the mPFC of seven
mice. In three out of the seven mice, FG was injected only
into the left hemisphere at the coordinates of 1.8 mm
anterior from the bregma, 0.3 mm lateral from the midline
and 2.7 mm below the zero level. In these cases, following
FG injections, we injected the retrograde tracer 0.5 %
Cholera toxin B subunit (CTB, List Biologicals, Campbell,
CA, USA) into the HIPP of the left hemisphere at three
coordinates: 2.5, 2.8, 3.2 mm posterior from bregma, 1.6,
1.6, 1.7 mm lateral from midline and 2.1, 2.1, 2.2 mm
below the zero level, respectively. In the other four mice,
FG was injected bilaterally into the PFC at the coordinates
given above, and CTB was injected into the MS at the
coordinates 1.0 mm anterior from bregma, in the midline
and 4.1 mm below the zero level. We injected 14–18 nl of
FG and 18–23 nl of CTB into every single injection spot
using the Nanoject-R pump. The coordinates were defined
according to the atlas by Paxinos and Franklin (2012). In
some cases we used unilateral injections, the reason of
which is that the chance of missing the target brain area
increases with the number of injections and having more
than four injections decreased the chance of the animal to
survive. Therefore, we did not want to raise the number of
injections in the mPFC-HIPP injected animals, where we
already carried out four injections per mouse. After the
surgeries, the animals received 0.5–0.7 ml saline and
0.03–0.05 mg/kg meloxicam (Metacam, Boehringer In-
gelheim, Germany) intraperitoneally, and we placed them
into separate cages to survive for 8–14 days before
perfusions.
Antibodies
We summarized the antibodies used in Table 1. The
specificity of the antibodies for vesicular glutamate trans-
porter type 3 (vGluT3), neuroligin 2 (NLGN2) and NMDA
receptor GluN2A-subunit (GluN2A) was tested extensively
before in experiments using wild-type and vGluT3-/-,
NLGN2-/- or GluN2A-/- null-mutant mice, respectively
(Watanabe et al. 1998; Szabadits et al. 2011; Taka´cs et al.
2013). Here, we confirm again the specificity of the guinea
pig anti-vGluT3 antibody, using vGluT3-/- null-mutant
mice. After subsequent washes in PB and TBS, the sections
containing the MRR or HIPP were incubated in a primary
antibody solution containing the guinea pig anti-vGluT3
antibody (1:1,000 or 1:4,000, respectively) for 48 h. After
subsequent washes in TBS, the sections containing the
MRR were incubated in a secondary antibody solution
containing Alexa 488 conjugated goat anti-guinea pig
antibody (1:1,000), and the sections containing HIPP were
incubated in a secondary antibody solution containing
biotinylated goat anti-guinea pig antibody (Vector Labo-
ratories, 1:200) overnight. The following treatment and
immunoperoxidase reaction were performed as described
below. We did not see any specific-like labeling in the
vGluT3-/- mouse strain (Fig. 4d1–d6). The anti-FG and
anti-CTB antibodies showed no labeling in animals that
were not injected with the respective retrograde tracers.
The rat anti-serotonin (5HT) antibody was characterized
before by (Amilhon et al. 2010) and we also detected a
similar staining pattern for serotonin, which further con-
firms its specificity.
Secondary antibodies were also extensively tested for
possible cross-reactivity with the other secondary or
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primary antibodies used here, and possible tissue labeling
without primary antibodies was also tested to exclude auto-
fluorescence or specific background labeling by the sec-
ondary antibodies. No specific-like staining was observed
under these control conditions.
Double-labeling immunoelectron microscopy
For NLGN2, GluN2A and vGluT3 immunolabeling, after
perfusion of four wild-type mice and removal of their
brains from the skull, coronal sections were cut on a Leica
VT1200S vibratome at 50 lm. This was followed by
washing out the fixative in 0.1 M phosphate buffer (PB) for
1 h. Then, the sections were cryo-protected sequentially in
10 % (overnight) and 30 % (2 h) sucrose in PB and freeze-
thawed three times over liquid nitrogen. For synaptic
detection of NLGN2, the sections were washed subse-
quently in 0.1 M PB following tris buffered saline (TBS)
and blocked in 1 % human serum albumin (HSA; Sigma-
Aldrich) in TBS. Then, they were incubated in a mixture of
primary antibodies for NLGN2 (rabbit, 1:600) and vGluT3
(guinea pig, 1:3,000) diluted in TBS. For synaptic detection
of NMDA receptors, pretreatment with pepsin was essen-
tial (Watanabe et al. 1998). The sections were incubated in
0.2 M HCl solution containing 1 mg/ml pepsin (Dako) at
37C for 10 min. They were then incubated in 50 mM
glycine (Sigma-Aldrich) and blocked in 1 % HSA in TBS,
followed by incubation in a mixture of primary antibodies
for GluN2A subunit (rabbit; 1:250) and vGluT3 (guinea
pig; 1:4,000) diluted in TBS containing 0.1 % BSA-c
(BSA-c/TBS; Aurion) for 72 h. For anterograde tracing
experiments, the primary antibody solution contained only
the anti-GluN2A-antibody. After repeated washes in TBS,
the sections labeled for NLGN2 were incubated in blocking
solution (Gel-BS) containing 0.2 % cold water fish skin
gelatine and 0.5 % HSA in TBS for 1 h. The sections
labeled for GluN2A were washed intensively in BSA-c/
TBS. After this, both series of the sections were incubated
in mixtures of secondary antibody solutions containing
1.4 nm gold-conjugated goat anti-rabbit (Fab’-fragment; in
a concentration of 1:100 in NLGN2 experiments and 1:300
for GluN2A staining) and biotinylated goat anti-guinea pig
(Vector Laboratories, 1:200) diluted in Gel-BS or BSA-c/
TBS, respectively, for 24 h. For anterograde tracing
experiments, the secondary antibody solution contained
only the gold-conjugated goat anti-rabbit antibody. After
intensive washes in TBS or BSA-c/TBS, the sections were
treated with 2 % glutaraldehyde in 0.1 M PB for 15 min to
fix the gold particles into the tissue. To develop the tracer
or vGluT3 labeling, this was followed by incubation in
avidin–biotinylated horseradish peroxidase complex (Elite
ABC; 1:300; Vector Laboratories) diluted in TBS for 3 h.
Table 1 Antibody specifications
Raised against Raised
in
Protein cc. of stock
solution
Dilution Source Catalog
number
Lot number Characterized
Neuroligin 2 Rabbit 1,000 lg/ml 1:600 Synaptic
Systems
129 203 10 Taka´cs et al. (2013)
GluN2A Rabbit 542 lg/ml 1:150–1:250 Gift of M.
Watanabe
– – Watanabe et al. (1998)
vGluT3 Guinea
pig
Not available 1:1,000–1:4,000 Millipore AB 5421 LV1453193 Szabadits et al. (2011),
present study
serotonin Rat Not available 1:500 Millipore MAB 352 2168248 Amilhon et al. (2010)
Fluoro-Gold Rabbit Not available 1:10,000–1:30,000 Millipore AB153 2003657 Varga et al. (2002)
Cholera toxin B
subunit
Goat Not available 1:20,000 List
Biologicals
703 7032A7 Dederen et al. (1994)
Cholera toxin B
subunit
Mouse 1,000 lg/ml 1:400 Abcam ab1003 – Hamorsky et al. (2013)
Conjugated with Raised in Raised against Dilution Source Catalog number Molecule
1.4 nm nanogold Goat Rabbit 1:100–1:300 Nanoprobes #2004 Fab’-fragment
Biotin Goat Guinea pig 1:200 Vector laboratories BA-7000 Whole IgG
Alexa 647 Chicken Rat 1:500 Life technologies A-21472 Whole IgG
Alexa 488 Goat Guinea pig 1:1,000 Molecular probes A-11073 Whole IgG
Alexa 488 Donkey Rabbit 1:500–1:1,000 Life technologies A-21206 Whole IgG
Alexa 594 Donkey Goat 1:500 Life technologies A-11058 Whole IgG
DyLight 549 Donkey Mouse 1:500 Jackson immunoresearch 715-505-151 Whole IgG
DyLight 405 Streptavidin Not antibody 1:500 Jackson immunoresearch 016-470-084 Streptavidin
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The immunoperoxidase reaction was developed using DAB
(3,3-diaminobenzidine; Sigma-Aldrich) as chromogen. To
enlarge immunogold particles, this was followed by incu-
bation in silver enhancement solution (SE-EM; Aurion) for
40 min at room temperature. The sections were treated
with 0.5 % osmium tetroxide in 0.1 M PB on ice and they
were dehydrated in ascending alcohol series and in aceto-
nitrile and embedded in Durcupan (ACM; Fluka). During
dehydration, the sections were treated with 1 % uranyl-
acetate in 70 % ethanol for 20 min. After this, the 100-nm-
thick serial sections were prepared using an ultramicrotome
(Leica EM UC6) and picked up on single-slot copper grids.
The sections were examined using a Hitachi H-7100
electron microscope and a Veleta CCD camera.
Analysis of immunogold electron microscopic
experiments
Randomly sampled vGluT3-positive terminals establishing
synaptic contacts with the somata or proximal dendrites of
interneurons located at the border of stratum radiatum and
lacunosum-moleculare were fully reconstructed in the
HIPP. In tracing experiments, BDA-labeled terminals were
randomly sampled and fully reconstructed in the HIPP, MS
and mPFC. The membrane-associated gold particles, i.e.
those that were within 40 nm from the membrane, labeling
the GluN2A subunit of the NMDA receptors were counted
on the postsynaptic side of the synapses established by
these terminals to determine the density of gold particles,
and the proportion of GluN2A-positive synapses. The
reason for using 40 nm is the following. The C-terminus
epitope of the NMDAR is located a few nanometers away
from the membrane, intracellularly. This is labeled with
one antibody, the latter of which is also labeled with yet
another antibody. Based on the data obtained with atomic
force microscopy and individual-particle electron tomog-
raphy studies (San Paulo and Garcı´a 2000; Zhang and Ren
2012), we calculated with 15–18 nm/IgG plus 6–7 nm/
Fab’-fragment. These, together with the 10–15 nm diam-
eters of the silver-enhanced gold particles make up the
40-nm band, in which we counted gold particles, to make
sure that we do not exclude real labeling.
Gold particles were also counted on the postsynaptic
side of fully reconstructed DAB-negative asymmetric
(putative glutamatergic excitatory) synapses, on a 200-nm-
long extrasynaptic membrane segment measured from both
edges of the very same synapses, and to determine the
background labeling, we also examined the presynaptic
terminal membrane of these synapses. The density of the
immunogold particles on the postsynaptic active zones
were always 30–120 times higher compared to the back-
ground that confirms the specificity of the labeling proce-
dure. We measured the areas of fully reconstructed
synapses established by the MRR and by local excitatory
terminals in the very same BDA-GluN2A double reactions,
in different serial sections. To prevent sampling bias,
stereological rules were applied in the experiments. Larger
synapses would be sampled more likely, if stereological
rules are not observed. To avoid this sampling bias, we
randomly sampled synapses in a given tissue volume that
started in that volume regardless of the size of the given
synapse. Therefore, during reconstruction of asymmetric
synapses, we randomly selected synapses that were not
present in the lookup section above, but once we selected a
synapse, we reconstructed it regardless of its size. The
largest asymmetric synapses can be reconstructed from up
to six serial sections. Therefore, we used only those tissue
volumes, where we could test another six sections below
the test volume.
Retrograde tracing and fluorescent confocal microscopy
The stereotaxic injection of the retrograde tracers, perfu-
sion, and sectioning of the brains was performed as
described above. In case of four mice, after subsequent
washes in PB and TBS, the sections were incubated in a
mixture of primary antibodies for FG (rabbit; previously
exhausted on native slices in 1:1,000 for 1 h and after that
diluted to 1:10,000) and CTB (goat; 1:20,000) for 48–72 h.
In case of another three mice, the primary antibody solu-
tion contained anti-FG (rabbit; exhausted, 1:10,000), anti-
CTB (mouse; 1:400), anti-vGluT3 (guinea pig; 1:1,000)
and anti-serotonin (rat; 1:500) antibodies diluted in TBS.
After subsequent washes in TBS, the sections were incu-
bated overnight in a mixture of the following secondary
antibodies: Alexa 488 conjugated donkey anti-rabbit
(1:500) and Alexa 594 conjugated donkey anti-goat
(1:500); or Alexa 488 conjugated donkey anti-rabbit
(1:500), DyLight 549 conjugated donkey anti-mouse,
Alexa 647 conjugated chicken anti-rat (1:500) and biotin-
ylated goat anti-guinea pig (1:200). After that, the second
set of vials was washed in TBS for 1 h and incubated in a
tertiary solution containing DyLight 405 streptavidin dis-
solved in TBS for 5 h. After washes in TBS and PB, the
sections were transferred to slides, and covered with
Aquamount (BDH Chemicals Ltd.).
Analysis of retrograde tracing experiments
Every single injection site was reconstructed from the
50-lm-thick sections using a Zeiss Axioplan2 microscope,
to estimate what percentage of the examined brain area was
injection labeled with the tracer. Every part of the target
tissue containing low levels of the tracer was considered to
be the part of the injection site. We fitted every image of
the injection sites to the corresponding outlines of the atlas
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(Paxinos and Franklin 2012), and determined the ratio of
the volumes of the injection sites to the examined brain
area, using the Fiji/ImageJ software. The brain areas we
measured were the following based on the atlas: in case of
the hippocampus, the dentate gyrus and the regions CA1-3;
in case of the medial septum, the medial septal area and the
diagonal bands of Broca; in case of the medial prefrontal
cortex, the areas A24a-b (anterior cingulate cortex), A25
(infralimbic cortex), A32 (prelimbic cortex) and medial
orbital cortex.
In case of the double-labeling experiments, the 50-lm-
thick sections of the midbrain containing the median raphe
were analyzed using an Olympus Optical FluoView 300
confocal laser scanning microscope in sequential scanning
mode. Every single section of the median raphe region was
reconstructed in z-stacks with 5 lm resolution. Cells were
counted using Adobe Photoshop software.
In case of the quadruple labeling experiments, we used a
Nikon A1R confocal laser scanning microscope system to
completely reconstruct every single section in z-stacks with
2 lm resolution. FG or CTB-labeled cells were counted,
and their 5HT or vGluT3-content was determined using the
NIS Elements software. To prevent stereological bias in
these experiments, the relative ratios of the different cell
types in these areas were corrected by the size of the cells
using Abercrombie’s correction.
In every experiment, we analyzed the median raphe
(MR) and paramedian raphe (PMR) subregions of the
median raphe region (MRR) separately. In every analyzed
section, we defined the border of the MRR and its subre-
gions using the atlas (Paxinos and Franklin 2012). During
the different measurements, we found no difference
between any measured features of the cells located at the
two subregions, except that the density of the cells was
obviously higher in MR.
Results
NMDA receptors are present in synapses established
by MRR in the hippocampus
To examine whether these MRR synapses resemble the
classical excitatory synapses, here, we examined whether
they contain GluN2A subunit of the NMDA-type glutamate
receptors. In the first set of experiments, we injected the
anterograde tracer 10 kDa BDA into the MRR of three
mice (Fig. 1a), and after 7–10 days of survival, we per-
formed double immunogold–immunoperoxidase labeling
for the GluN2A subunit of the NMDA receptors and for
BDA. At the light microscopic level, BDA labeling showed
the known pattern of MRR innervation in the HIPP (Freund
et al. 1990; Vertes et al. 1999), i.e., there were several
immunoperoxidase-positive fibers and terminals in the
distal dendritic regions of the hippocampal pyramidal cells,
in the outer third of the stratum radiatum and in stratum
lacunosum-moleculare. Using correlated light and electron
microscopy, we fully reconstructed 42 randomly sampled
raphe-hippocampal synapses in the CA1 region of the
HIPP, at the distal dendritic regions of hippocampal
pyramidal cells (n = 15, 12 and 15 in 3 mice, respec-
tively). These synapses target the somata of local inter-
neurons or with putative interneuronal dendritic segments.
According to our measurements, about one-third of the
raphe-hippocampal synapses contained the GluN2A sub-
unit in their postsynaptic active zones (Fig. 1b1–b3). For
statistical details see Fig. 3c.
We also analyzed the density of immunogold labeling
along different membrane segments. Although these pre-
embedding immunogold measurements are only semi-
quantitative, they are proved to be suitable for a good
approximation of the differences between membrane
receptor densities. GluN2A subunit immunogold labeling
was present in the postsynaptic active zones of synapses
established by MRR terminals and in classical excitatory
synapses as well. The density of the immunogold particles
in the raphe-hippocampal synapses was not much lower
than that in adjacent local classical excitatory synapses.
Rarely, immunogold particles were also found in extrasy-
naptic membrane segments as described previously
(Szabadits et al. 2011). The background labeling measured
on the presynaptic terminals of classical excitatory syn-
apses was negligible. For statistical details see Fig. 3d.
To estimate the absolute NMDA receptor content of the
different kinds of synapses, we measured their synaptic
area using fully reconstructed synapses. Our data show that
the synapses established by MRR in the HIPP have a larger
area than the classical excitatory synapses (Fig. 3e). To
calculate the total amount of gold labeling in our synapses,
we multiplied the GluN2A immunogold density with the
measured areas. We found that the synapses established by
MRR and classical excitatory terminals (0.41 ± 0.24 vs.
0.38 ± 0.20 gold particles/synapse, respectively) contain
similar amount of average labeling, suggesting that, on
average, they act through similar amount of NMDA
receptors.
To further confirm these results, we performed another
set of experiments using vGluT3-GluN2A double immu-
nolabeling. There are two sources of vGluT3-containing
terminals in the HIPP: the first originates from basket cells
and establishes synaptic contacts in the stratum pyramidale
on the perisomatic region of pyramidal cells, while the
second originates from MRR and establishes synapses on
the somata and proximal dendrites of interneurons located
in the outer third of the stratum radiatum and in stratum
lacunosum-moleculare (Somogyi et al. 2004). At the light
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microscopic level, we found the classical pattern of
vGluT3-positive terminal labeling (and we found several
immunopositive interneurons as well). Because vGluT3
labels the majority of the terminals of the MRR that
innervate the HIPP, we could collect a larger sample of
synapses from the surface of the sections, where the
immunoreaction was the strongest. Only those synapses
were included in these measurements that were established
on the somata of interneurons. We found in two mice that
almost all of these synapses established by vGluT3-positive
terminals (n = 20 synapse/mouse) contain the GluN2A
subunit of the NMDA receptors (about 90 %, Fig. 1c–e).
For exact percentages see Fig. 3a. We also compared the
density of the gold particles in the synapses established by
vGluT3-positive terminals to that of the adjacent local
classical excitatory synapses, and we found that their ratios
are similar to those measured in the anterograde tracing
experiments (compare Fig. 3b, d).
However, some terminals of the vGluT3-positive GAB-
Aergic basket cells may target the distal dendritic regions.
To determine the exact distribution of these basket cell
terminals in the distal dendritic layers, we performed double
immunogold–immunoperoxidase labeling for neuroligin 2
(NLGN2) and vGluT3. NLGN2 is a postsynaptic
transmembrane protein present in the GABAergic (Va-
roqueaux et al. 2004) and cholinergic synapses (Taka´cs
et al. 2013). At the electron microscopic level, NLGN2
labeling was associated with postsynaptic membranes. We
found that only about 10 % of the examined vGluT3-posi-
tive terminals contained NLGN2 postsynaptically in the
CA1 region (49 and 39 serially reconstructed synapses in
two mice, respectively; for details, see Fig. 3a). In contrast,
adjacent vGluT3-negative (putative GABAergic) symmet-
ric synapses were always NLGN2-positive (Fig. 1f). Taking
into account that about 90 % of the synapses established by
vGluT3-positive terminals are established by MRR in these
layers, at least about 88 % of the MRR-HIPP synapses
express NMDA receptors according to these measurements.
These data show higher percentages than those found in the
tracing experiments, because here we could collect syn-
apses from the surface of sections, where digestion and
penetration parameters were more optimal.
NMDA receptors are present in the synapses
established by MRR in the MS and mPFC
MRR innervates not only the HIPP, but also many other
forebrain areas (Vertes et al. 1999; Bang et al. 2012). To
Fig. 1 NMDA receptors are present in the postsynaptic active zones
of MRR-HIPP. Synapses a Light micrograph showing a representa-
tive injection site of 10 kDa BDA into the median raphe region that
comprises of the median raphe (MR) and paramedian raphe (PMR).
Scale bar 200 lm. b–f Electron micrographs of synapses show
combined immunogold–immunoperoxidase reactions from the border
of str. radiatum and lacunosum-moleculare of the CA1 region of the
HIPP. Scale bar for all: 300 nm. b1–b3, c1–c3, d, e1–e2 The
immunogold particles (arrowheads) label the GluN2A subunit of
the NMDA receptor located postsynaptically in the synapses estab-
lished by presynaptic terminals of MRR fibers, filled with dark DAB
precipitate, corresponding either to the anterograde tracer BDA (b1–
b3) or to vGluT3 (c–e) labeling. b1–b3, c1–c3 and e1–e2 Consecutive
sections of the very same synapses, respectively. f Neuroligin-2
(immunogold particles, thin arrows) is present on the postsynaptic
side of a putative GABAergic synapse established by a vGluT3-
negative terminal, but it is absent from the synapse of a vGluT3-
positive terminal (thick black arrow)
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investigate whether NMDA receptors are present in other
forebrain areas, we also analyzed BDA-labeled terminals in
the MS and in the mPFC. At the light microscopic level,
MS shows strong innervation from the MRR. In the mPFC,
we found a few basket-like varicosities with approximately
5–10 terminals in a group. Using correlated light and
electron microscopy, we fully reconstructed 45 and 44
synapses in the MS (Fig. 2a1–a4, b, c) and in the mPFC
(Fig. 2d1–d2, e1–e3, f), respectively (n = 15, 15, 15 from
MS and n = 15, 14, 15 for mPFC in three mice, respec-
tively). According to our measurements, at least about
40 % of the synapses established by BDA-positive termi-
nals in the MS and at least about the half of them in the
mPFC contained GluN2A in their postsynaptic active zone,
respectively (Figs. 2, 3c).
The density of the GluN2A immunogold particles was
also measured in the MRR-MS and MRR-mPFC synapses,
and these values were not much lower than the immuno-
gold content of adjacent local classical excitatory synapses;
for details, see Fig. 3f, h. We found some extrasynaptic
membrane immunogold labeling in these areas as well, and
only a negligible background labeling.
To estimate the absolute receptor content of the syn-
apses established by MRR in the MS and mPFC, we
measured their area, similar to that in the HIPP (see above).
We found that on average, the area of the synapses
established by MRR in the MS and mPFC is again larger
compared to that of the local classical excitatory synapses
(Fig. 3g, i). The total amount of gold particles in the MRR-
MS and MRR-mPFC synapses was similar to that in the
local classical excitatory synapses (0.89 ± 0.48 vs.
0.65 ± 0.40 gold particles/synapse in the MS, and
0.92 ± 0.42 vs. 0.52 ± 0.24 gold particles/synapse in the
mPFC, respectively). Taken together, these data show that
the immunolabeling profile is very similar in the three
examined target areas (Fig. 3d–i).
Fig. 2 NMDA receptors are present in the postsynaptic active zones
of synapses established by MRR in the MS and mPFC. Electron
micrographs of synapses show combined immunogold–immunoper-
oxidase reactions from the MS (a1–a4, b, c) and mPFC (d1–d2, e1–e3,
f). The immunogold particles (arrowheads) show the GluN2A subunit
of the NMDA receptor postsynaptically in the synapses established by
presynaptic terminals of MRR fibers, labelled with the anterograde
tracer BDA (dark DAB precipitate). a1–a4, d1–d2 and e1–e3 Show the
consecutive sections of the very same synapses, respectively. Scale
bar 500 nm
cFig. 3 Graphs summarizing the data acquired with immunoelectron
microscopy. a The columns show vGluT3-positive terminals that
establish synapses on somata or proximal dendrites of interneurons at
the distal dendritic region of the CA1. The percentages show the
proportions of synapses containing NLGN2 or GluN2A postsynap-
tically, respectively. b Average densities of the immunogold particles
in different membrane domains of the two mice used for vGluT3–
GluN2A double immunohistochemical measurements. The columns
show the density of immunogold particles in synapses established by
vGluT3-positive (mostly MRR) terminals (vGluT3 term) or local
excitatory terminals (excit term) and extrasynaptic labeling measured
200 nm away from both edges of the postsynaptic side of the
excitatory synapses (extra), and background labeling measured on the
presynaptic side of the same synapses (backg). The total amount of
measured membrane domain area is indicated in lm2 s, respectively.
c Percentages of the synapses established by BDA-labelled terminals
containing postsynaptic GluN2A labeling in the HIPP, MS and
mPFC. The data were collected from three mice. d, f, h Average
densities of the immunogold particles in different membrane domains
in three mice used for BDA-GluN2A double immunohistochemical
measurements in the HIPP, MS and mPFC, respectively. The columns
show the density of immunogold particles in synapses established by
BDA-labelled MRR inputs (MRR term) or local excitatory terminals
(excit term) and extrasynaptic labeling measured on a 200-nm-long
extrasynaptic membrane segment from both edges of the very same
synapses (extra), and background labeling measured on the presyn-
aptic side of the same synapses (backg). The total amount of
measured membrane domain area is indicated in lm2 s. e, g, i The
columns show the average synaptic areas of raphe inputs (MRR term)
and local excitatory synapses (excit term) in three mice used in BDA-
GluN2A double immunohistochemical measurements in the HIPP,
MS and mPFC, respectively. Error bars indicate standard deviations.
The total number of totally reconstructed synapses are indicated in the
columns
Brain Struct Funct
123
Brain Struct Funct
123
The majority of the MRR cells projecting
to the forebrain are glutamatergic
Although anterograde tracing experiments showed the
abundance of glutamate receptors in synapses established
by MRR in the forebrain, we wanted to know whether the
presence of vGluT3 is also typical in these projections. We
injected the retrograde tracers CTB into the HIPP or MS
and FG into the mPFC, and we performed quadruple
staining for FG, CTB, vGluT3 and 5HT (Figs. 4, 5). We
analyzed the median raphe (MR) and paramedian raphe
(PMR) subregions of the median raphe region (MRR)
separately, but we found no difference between any mea-
sured cell ratios, except that the density of the cells was
obviously higher in MR; therefore, we report data pooled
for the whole MRR.
Glutamatergic HIPP and MS projections were reported
previously in the rat (Jackson et al. 2009) and, here, we
confirmed that this is similar in the mouse. In case of the cells
projecting to the HIPP, we found that about 80 % of them
contain vGluT3 with or without containing 5HT and only
8 % was only 5HT-positive. In case of the cells projecting to
the MS, we found that about half of them contain vGluT3
with or without containing 5HT and only about 11.5 % was
only 5HT-positive. For exact percentages, see Table 2.
The neurochemical identity of the MRR cells projecting
to the mPFC was not examined before. We found that
about 70 % of them contain vGluT3, while most of those
are only vGluT3-positive and only about 16 % was only
5HT-positive. See Table 2 for details.
Single cells of the MRR project to the HIPP and mPFC
simultaneously
If single glutamatergic MRR cells could innervate more
than one brain area, they could conduct a highly effective
synchronous modulation of the network activity in those
forebrain areas; therefore we investigated whether the same
MRR cells can project to HIPP and mPFC as well. We
injected the retrograde tracers CTB into the HIPP, and FG
into the mPFC of the left hemisphere of three mice. Then,
we performed immunofluorescent staining on the sections
containing the MRR (Fig. 4). This type of investigation
inherently leads to an underestimation of the number of the
double-projecting cells, for several reasons: (i) we could
not completely label the target brain areas without jeop-
ardizing tracer leakage to adjacent brain areas, which we
managed to avoid; (ii) MRR fibers may arborize only in a
subregion of the target nucleus and these subregions may
or may not be labeled by the tracer and (iii) MRR fibers
may take up the injected tracer with low probability, if their
arborization is scarce in the injection labeled area. Taken
these limitations and the percentage of the injection labeled
areas into account, we found a large amount of cells pro-
jecting to both injection labeled forebrain areas. For details,
see Table 3. In the mouse having the largest injection
labeled area (13 % of the HIPP and 13 % of the mPFC),
about 9–12 % of the cells projecting to one area also
projected to the other area.
To determine the neurochemical identity of these cells,
we performed vGluT3 and 5HT labeling in the MRR of one
mouse. We found, that more than 90 % of the double-
projecting cells contained vGluT3, and the majority of
those also contain 5HT (Table 3).
Single cells of the MRR project to the MS and mPFC
simultaneously
To investigate whether the same MRR cells can project to
the MS as well as to the mPFC, we injected the retrograde
tracers CTB into the MS, and FG into the mPFC of both
hemispheres of four mice. Then, we performed immuno-
fluorescent staining on the sections containing the MRR
(Fig. 5). In the mouse having the largest injection labeled
area (23 % of the MS and 17 % of the mPFC), about
11–16 % of the cells projecting to one area also projected
to the other area. In two mice, we checked the vGluT3 and
5HT content of the cells projecting to both forebrain areas.
We found that 67–93 % of them contain vGluT3 and about
one-third of these cells were immunoreactive for 5HT as
well (Table 4).
cFig. 4 Single cells of the median raphe project to the HIPP and
mPFC simultaneously. a1–a2 Fluorescent micrographs show repre-
sentative injection sites of FG (a1) and CTB (a2) into the ipsilateral
mPFC and HIPP, respectively. A24a, A25, and A32 subregions of the
mPFC, the CA1, CA3 regions of the HIPP and the dentate gyrus (DG)
are indicated in the images. Scale bar 200 lm. b1–b4 Maximal
intensity projections of three image planes of confocal laser scanning
images show the same representative median raphe region comprising
of median raphe (MR) and paramedian raphe (PMR). FG (green)
labels cells projecting to the mPFC, CTB (red) labels cells projecting
to the HIPP, vGluT3 (blue) labels glutamatergic cells and 5HT
(magenta) labels serotonergic cells. The area c on B1 indicates the
position of images (c1–c4). Scale bar 100 lm. c1–c4 Magnified
images of the same cluster of MRR cells. Open arrow marks a cell
projecting to the mPFC, containing vGluT3 and 5HT; arrowhead
marks a cell projecting to the HIPP, immunoreactive only for 5HT;
closed arrows mark cells that project to both forebrain areas; the
upper cell contains vGluT3 and 5HT, while the lower cell contains
only vGluT3. Scale bar 30 lm. d1–d6 Images showing the specificity
of vGluT3-staining using the guinea pig anti-vGluT3 antibody on
wild-type (WT) and on vGluT3-/- null-mutant (KO) mice. Repre-
sentative images show immunoperoxidase reactions in the pyramidal
cell layer (pyr, d1–d2) and in the border of stratum radiatum and
lacunosum-moleculare (lmr, d3–d4) of the HIPP. Maximal intensity
projections of three image planes of confocal laser scanning images
show immunofluorescent reactions in the MRR (d5–d6). Arrowheads
show vGluT3-positive somata in the WT mouse, while no specific-
like staining was observed in the KO mouse. Scale bars 30 lm
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Discussion
Using several immunohistochemical approaches in the
mouse, we found in this study that: (1) NMDA receptors
are present in the postsynaptic active zones of the synapses
established by the MRR in the HIPP, MS and mPFC. (2)
The majority of the cells in the MRR projecting to the
mPFC are glutamatergic, similar to those projecting to
HIPP and MS. (3) Several cells of the MRR project to more
than one forebrain areas and they are also mostly gluta-
matergic. These data show that the majority of the output
of the MRR is glutamatergic and it can act through NMDA
receptor-containing synapses, suggesting that the primary
function of the MRR may be to excite key GABAergic
cells in the forebrain, while serotonin may be an important
modulator of this transmission.
Possible role of NMDA receptors in the synapses
established by MRR in the forebrain
Previously, we found in the rat (Varga et al. 2009) that a
functional serotonergic and glutamatergic cotransmission is
present in synapses established by the MRR in the HIPP
and about 75 % of the amplitude of photostimulation-
evoked excitatory postsynaptic potentials was glutamater-
gic at these synapses. The receptor content of the synapses
established by MRR was examined only in the same study
(Varga et al. 2009), where we showed their AMPA receptor
content in the HIPP. However, here, in the mouse, we show
that not only these synapses, but also other MRR synapses
in the forebrain contain NMDA receptors. These two types
of receptors are the typical components of the classical
excitatory synapses and explain the robust, fast excitation
conveyed by glutamatergic afferents.
MRR innervates its target cells efficiently: a subpopu-
lation of hippocampal interneurons can receive up to 40
boutons from the MRR to their somata and dendrites (Fre-
und et al. 1990; Aznar et al. 2004). Similar innervation of
MRR fibers was found around parvalbumin- and calbindin-
positive somata in the MS of the rat, establishing about 3–5
terminals per somata (Leranth and Vertes 1999; Aznar et al.
2004). We also observed this perisomatic innervation pro-
file of the MRR in the mouse not only in the MS, but also in
the mPFC and these large terminals were similar to those
described by Kosofsky and Molliver (1987).
We found that the majority of the cells projecting to all of
these brain areas are glutamatergic. Our results showed that a
large proportion of the synapses established by these termi-
nals are positive for NMDA receptors in every examined
brain area. The proportion of GluN2A-positive synapses of
the MRR is high in the HIPP, where, according to our mea-
surements, nearly 90 % of synapses established by the
vGluT3-positive terminals of the MRR contain NMDA
receptors. Furthermore, our calculation, based on our semi-
quantitative data, showed similar amount of NMDA recep-
tors in the synapses of MRR compared to that in local
adjacent asymmetric synapses. These excitatory basket-like
innervations can be highly effective in modulating or even
overwriting the activity of the innervated cells. Indeed, we
previously showed in the rat a disynaptic inhibition of hip-
pocampal pyramidal cells by these interneurons after MRR
stimulation (Varga et al. 2009). The similar anatomical
composition of these synapses in the mouse HIPP, MS and
mPFC suggests that MRR can exert a fast subcortical control
not only in the HIPP but also in the other forebrain areas.
Interaction of synaptic NMDA receptors
and the serotonergic neurotransmission
Interestingly, cooperation between the serotonergic and
glutamatergic neurotransmitter system has already been
described in different species in many central nervous
system areas (Amilhon et al. 2010; de Bartolomeis et al.
2013) and NMDA receptors were also shown to take part in
these regulatory mechanisms (Maura et al. 2000; MacLean
and Schmidt 2001; Yuen et al. 2005). Functional 5HT3
receptors are present in the interneurons of the HIPP
(Ropert and Guy 1991; McMahon and Kauer 1997; Varga
et al. 2009), and they were also shown to be present in
GABAergic cells of the MS and mPFC (Morales and
Bloom 1997; Puig et al. 2004). Although, it was not pos-
sible to directly examine the possible synaptic co-locali-
zation of NMDA receptors and 5HT3 receptors, previously,
we showed that MRR synapses in the rat HIPP act trough
5HT3 receptors and glutamate receptors (Varga et al.
2009). Here, we show that these glutamate receptors are at
least partly NMDA receptors, which suggest their interac-
tion in this connection as well. Interestingly, the current–
voltage curve of the 5HT3 receptor is dependent on the
extracellular Ca2? level (McMahon and Kauer 1997),
which may be temporarily depleted by NMDA receptors
(Arens et al. 1992; Vassilev et al. 1997). In addition,
depolarization mediated by 5HT3 receptor could also help
to remove the voltage-dependent Mg2? block from the
NMDA receptors. However, 5HT3-like receptors were also
shown to directly inhibit NMDA receptor-dependent
responses in pyramidal cells of the mPFC in a longer
timescale (Liang et al. 1998). In addition, 5HT was shown
to directly block NMDA responses in rat ventral spinal
cord cultures (Chesnoy-Marchais and Barthe 1996). Thus,
upon strong MRR activation, serotonin could exert a direct
temporary negative feedback of excitation, if these syn-
apses became over-activated, protecting the cell from ex-
citotoxicity. Taken together, the presence of NMDA
receptors at these synapses can reveal new explanations to
where these interactions may actually take place.
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MRR as an ascending glutamatergic nucleus:
the anatomical framework for synchronous excitation
of key forebrain inhibitory neurons
The first studies in the literature that suggested an
ascending non-serotonergic output from the rat MRR were
based on retrograde labeling experiments, showing that
5HT-negative MRR cells project to the HIPP or MS
(Ko¨hler et al. 1982; Ko¨hler and Steinbusch 1982; Acsa´dy
et al. 1996). Then, Aznar et al. (2004) found that only about
one-third of the anterogradely traced fibers of the MRR are
5HT-positive in the HIPP CA1 and CA3, and hardly any of
them are 5HT-positive in the MS and the diagonal band of
Broca in the rat. After that, Somogyi et al. (2004) showed
Fig. 5 Single cells of the median raphe project to the MS and mPFC
simultaneously. a1–a2 Fluorescent micrographs show representative
injection sites of FG (a1) and CTB (a2) into the bilateral mPFC and
MS, respectively. A24a, A24b, and A25 subregions of the mPFC,
medial septum (MS), vertical limb of the diagonal band of Broca
(VDB), septohippocampal nucleus (SHi) and lateral septum, inter-
mediate part (LSI) are indicated on the images. Scale bar 200 lm.
b1–b4 Maximal intensity projection images of three image planes of
confocal laser scanning micrographs show the same representative
median raphe region comprising of median raphe (MR) and
paramedian raphe (PMR). FG (green) labels cells projecting to the
mPFC, CTB (red) labels cells projecting to the MS, vGluT3 (blue)
labels glutamatergic cells and 5HT (magenta) labels serotonergic
cells. The area c on b1 indicates the position of images c1–c4. Scale
bar 100 lm. c1–c4 Magnified images of the same cluster of median
raphe cells. Open arrows mark cells projecting to the mPFC,
containing only vGluT3; arrowheads mark cells projecting to the
MS; the upper cell contains only vGluT3, while the lower cell
contains only 5HT; closed arrows mark cells that project to both
forebrain areas; the upper cell contains vGluT3 and 5HT, while the
lower cell contains only vGluT3. Scale bar 30 lm
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that some vGluT3-positive terminals in the HIPP are also
serotonergic. Then, Jackson et al. (2009) showed that
projecting cells, retrogradely labeled from the HIPP or MS
of the rat, may actually contain the vGluT3 in the MRR.
Finally, we showed in the rat that these vGluT3-containing
fibers can excite local interneurons in the HIPP (Varga
et al. 2009).
In mouse, so far only one study examined the possible
vGluT3 content of the MRR fibers. Amilhon et al. (2010)
found that about half of the 5HT-positive fibers in the
prelimbic cortex and HIPP of the mouse contain vGluT3.
However, the possible presence of non-serotonergic pro-
jecting cells was not examined there. Here, our results
show that the majority of cells in the MRR projecting to the
HIPP, MS and mPFC contain vGluT3 with or without 5HT
in the mouse (Table 2), suggesting that the glutamatergic
MRR projection is fundamental.
Only a few studies examined whether single MRR cells
in the rat can project to more forebrain areas simulta-
neously, but none of them examined the possible vGluT3
content of these double-projecting cells. Ko¨hler and col-
leagues identified cells in the rat MRR, projecting either to
the entorhinal cortex and HIPP or to the entorhinal cortex
and MS simultaneously (Ko¨hler et al. 1982; Ko¨hler and
Steinbusch 1982). In addition, it has been described that
single serotonergic MRR cells of the rat can project to the
MS and HIPP simultaneously (Acsa´dy et al. 1996; McK-
enna and Vertes 2001). None of these studies described
double-projecting non-serotonergic cells. Here, we descri-
bed that there is a significant population of cells in the
Table 2 Neurochemical
properties of retrogradely
labeled cells projecting to
different forebrain areas
Injected target area Number of retrogradely
labeled cells in MRR
Neurochemical identity of retrogradely labeled cells in
MRR
vGluT3? and
5HT? (%)
Only
vGluT3?
(%)
Only
5HT?
(%)
Unlabeled
(%)
Hippocampus
(mouse 5)
391 49 31 8 12
Medial septum
(mouse 6)
850 19 34 13 34
Medial septum
(mouse 7)
710 21 47 10 21
Medial prefrontal
cortex (mouse 5)
506 32 38 21 9
Medial prefrontal
cortex (mouse 6)
555 24 45 16 15
Medial prefrontal
cortex (mouse 7)
334 29 46 10 15
Table 3 Hippocampus-mPFC
double retrograde tracing
experiments and neurochemical
properties of double-projecting
cells of the MRR
Animal ID number Mouse 1 Mouse 2 Mouse 5
Percentage show the volume of the hippocampus that
was labeled with the injected tracer (%)
11 12 13
Percentage show the volume of the unilateral mPFC
that was labeled with the injected tracer (%)
8 9 13
Percentage of the cells projecting to the injection
labeled mPFC area out of all cells backlabeled from
the hippocampus
9/166 (5.4 %) 11/96 (11.5 %) 46/391 (11.9 %)
Percentage of the cells projecting to the injection
labeled HIPP area out of all cells backlabeled from
the mPFC
9/156 (5.8 %) 11/304 (3.6 %) 46/506 (8.7 %)
Neurochemical identity of cells that project to
both flooded forebrain areas
vGluT3? and 5HT? – – 71 %
Only vGluT3? – – 20 %
Only 5HT? – – 9 %
Unlabeled – – 0 %
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MRR that project to the HIPP and mPFC or the MS and
mPFC simultaneously, and most of them are glutamatergic.
This suggests that these cells can synchronously modulate
different brain areas in a fast and precise manner through
the excitation of the targeted inhibitory neurons. The HIPP,
MS and mPFC are heavily interconnected through several
direct and indirect pathways (Freund and Antal 1988;
Semba 2000; Heidbreder and Groenewegen 2003; Taka´cs
et al. 2008), therefore, the activation of key GABAergic
cells via excitatory inputs to these brain areas would be
highly effective in the modulation of their synchronous
activity patterns and cooperation.
Conclusion
Taken together, our findings further support that the MRR
can exert a fast and effective control of inhibition in
multiple forebrain areas through glutamatergic transmis-
sion. This effect can be mediated by NMDA receptors that
can cooperate well with the serotonergic system. More-
over, we conclude that the majority of the MRR cells
projecting to the HIPP, MS and mPFC are glutamatergic,
and these cells are in a perfect position to orchestrate the
network activity in these brain areas. Our findings shed
light on the structural background of the powerful modu-
lation exerted by a key subcortical modulatory center.
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